Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper.

aortic valve cardiac magnetic resonance imaging computed tomography echocardiography expert’s consensus mitral valve pulmonary valve tricuspid valve valvular regurgitation

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
18 04 2022
Historique:
received: 08 11 2021
accepted: 10 11 2021
pubmed: 17 3 2022
medline: 21 4 2022
entrez: 16 3 2022
Statut: ppublish

Résumé

Valvular regurgitation represents an important cause of cardiovascular morbidity and mortality. Imaging is pivotal in the evaluation of native valve regurgitation and echocardiography is the primary imaging modality for this purpose. The imaging assessment of valvular regurgitation should integrate quantification of the regurgitation, assessment of the valve anatomy and function, and the consequences of valvular disease on cardiac chambers. In clinical practice, the management of patients with valvular regurgitation largely relies on the results of imaging. It is crucial to provide standards that aim at establishing a baseline list of measurements to be performed when assessing native valve regurgitation. The present document aims to present clinical guidance for the multi-modality imaging assessment of native valvular regurgitation.

Identifiants

pubmed: 35292799
pii: 6549204
doi: 10.1093/ehjci/jeab253
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e171-e232

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2022. For permissions, please email: journals.permissions@oup.com.

Auteurs

Patrizio Lancellotti (P)

Department of Cardiology, Valvular Disease Clinic, University of Liège Hospital, GIGA Cardiovascular Sciences, CHU Sart Tilman, 4000 Liège, Belgium.
Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, Italy.
Anthea Hospital, Via Camillo Rosalba, 35, Bari, Italy.

Philippe Pibarot (P)

Department of Medicine, Québec Heart & Lung Institute, Laval University, 2725, chemin Sainte-Foy, Québec, Canada.

John Chambers (J)

Emeritus Professor of Clinical Cardiology, Guy's and St Thomas' Hospital, London SE1 7EH, UK.

Giovanni La Canna (G)

Cardiovascular Department, IRCCS Humanitas Clinical and Research Hospital, Applied Diagnostic Echocardiography, 20089 Rozzano, Milan, Italy.

Mauro Pepi (M)

Department of Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.

Raluca Dulgheru (R)

Department of Cardiology, Valvular Disease Clinic, University of Liège Hospital, GIGA Cardiovascular Sciences, CHU Sart Tilman, 4000 Liège, Belgium.

Mark Dweck (M)

BHF Centre for Cardiovascular Science, University of Edinburgh, Little France Crescent, Edinburgh EH16 4SB, UK.

Victoria Delgado (V)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2 2300 RC Leiden, The Netherlands.

Madalina Garbi (M)

Royal Papworth Hospital, Cambridge University Health Partner, Cambridge Biomedical Campus, CB2 0AY Cambridge, UK.

Mani A Vannan (MA)

Marcus Heart Valve Center, Piedmont Heart Institute, Atlanta, GA, USA.

David Montaigne (D)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France.

Luigi Badano (L)

Department of Medicine and Surgery, University of Milano-Bicocca, 20089 Milan, Italy.
Department of Cardiac, Metabolic and Neural Sciences, Istituto Auxologico Italiano, IRCCS, 20089 Milan, Italy.

Pal Maurovich-Horvat (P)

MTA-SE Cardiovascular Imaging Research Group, Medical Imaging Centre, Semmelweis University, 1083 Budapest, Hungary.

Gianluca Pontone (G)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Alec Vahanian (A)

UFR Medecine, Université de Paris, Site Bichat, 16 rue Huchard, 75018 Paris, France.
LVTS INSERM U1148, GH Bichat, 46, rue Henri Huchard, 75018 Paris, France.

Erwan Donal (E)

University of Rennes, CHU Rennes, Inserm, LTSI-UMR 1099, Rennes, France.

Bernard Cosyns (B)

Department of Cardiology, CHVZ (Centrum voor Hart en Vaatziekten), ICMI (In Vivo Cellular and Molecular Imaging) Laboratory, Universitair Ziekenhuis Brussel, 101 Laarbeeklaan, 1090 Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH